Coventry LPC



June 18, 2019 News0

Please be advised that pharmacies are no longer required to submit the monthly 100-hour monitoring forms to NHS England, effective immediately.

You may, however,  occasionally be asked for this information, for example if there’s a complaint raised regarding unexpected closure during core hours.

Please direct any queries regarding this matter to the NHS Pharmacy Team:



June 18, 2019 News0

A recorded version of the joint PSNC/NHSBSA Schedule of Payments webinar held on 11th June is now available on the following LINK. You need to register or log in to gain access.

If you would like to understand the payments your pharmacy receives from the NHS, this webinar will  provide some useful insights. Over  700 people registered for this webinar originally. If you missed it, here’s your chance to catch up.

The slide deck is also available to download HERE.


June 13, 2019 News0

The Serious Mental Illness Screening and Intervention service was recently launched in Coventry and Warwickshire in association with Central Health Solutions.

We have set up a web page for this pilot service compiling useful links and documents. You can find these resources HERE.

Pharmacies who have expressed interest in providing this service and have taken part in the necessary training can sign up on the CHS website HERE, if they haven’t done so already.


June 13, 2019 News0

With the introduction of Primary Care Networks, the NHS landscape is changing affecting all pharmacies!

The LPC, along with PSNC, is going to support pharmacies throughout this ongoing process. We have added a page to our website where you can find some useful resources. You can access the PCN page on this LINK.

This page also includes copies of our PCN Newsletters, the first issue of which has been emailed to all pharmacies. There will be further issues published as more information becomes available.

If you have any questions regarding PCNs, please do not hesitate to contact the LPC.


June 10, 2019 News0

Community Pharmacy Assurance Framework (CPAF) – arrangements for 2019/20

To ensure that patients and members of the public receive safe, effective and high quality pharmaceutical services, NHS England has processes in place to monitor compliance by pharmacy contractors, who are included in one of NHS England’s pharmaceutical lists, with the terms of service set out in the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 (the 2013 regulations).

One of these processes is the use of the Community Pharmacy Assurance Framework (CPAF) to be conducted in two parts.

Part One:  All pharmacy contractors to be invited to complete a short screening questionnaire consisting of ten questions to assure themselves and NHS England that they are compliant with the terms of service.

Part Two:  The data collected from this questionnaire along with other information held by NHS England to be used to shortlist pharmacies to be considered for a contract monitoring visit. Only these pharmacies are asked to complete a full CPAF questionnaire. A copy of the full questionnaire can be viewed here.

This approach means that the majority of contractors do not need to complete the full CPAF questionnaire. However, both the Pharmaceutical Services Negotiating Committee (the PSNC) and NHS England recommend that all pharmacy contractors make use of the full CPAF questionnaire to assure themselves that they are compliant with the terms of service.

Pharmacies will be asked to complete the screening questionnaire during June 2019 Please note that the CPAF screening questionnaire was updated in 2018 following development work by the CPAF working group, a working group with membership from NHS England, NHS Business Services Authority (NHSBSA) and the PSNC. The CPAF screening questionnaire again includes the two questions focusing on safeguarding and pharmacy audits; which replaced the questions on ‘owings’ and prescribed medicines advice, which have been retired and no longer need to be answered.

The NHS Business Services Authority (BSA) will carry out the administration of both the screening questionnaire and the full CPAF at a national level on our behalf and this is facilitated through a secure on-line mechanism to allow pharmacy contractors to complete their returns. The screening questionnaire is available to view in advance and can be found here. (Please note this link is for information purposes only. Contractors will have received information and instructions on how to access and complete the screening questionnaire securely online from the BSA.)

Contractors will have four weeks to complete the screening questionnaire which will be available from Monday 3 June 2019 with a closure date of Sunday 30 June 2019. The questionnaire should only take around 20 minutes to complete.

Once you have submitted the completed questionnaire you will have the facility to save, print or access your responses for further reference.

Thank you in advance for your cooperation with this exercise.

If you have any questions regarding this questionnaire, please contact The Pharmacy Team at

Further guidance is available in this PSNC Briefing.

A timeline of the 2019/2020 CPAF process can be viewed HERE.

We have also set up a permanent CPAF page, which can be accessed HERE.


June 4, 2019 News0

The Interim People Plan has been published by the NHS, which sets out how the workforce will be supported to deliver the care that the NHS needs to fulfil the NHS Long-term Plan.

In addition, a briefing has been published specifically relating to the pharmacy work force:

PSNC have compiled a summary of the key points in this briefing as follows:

  • Community pharmacists should have greater freedom to deliver more clinical care, as pharmacy technicians are supported and encouraged to practise at the top of their licence;
  • Introduction of a common foundation programme for all newly registered pharmacists;
  • New training to support community pharmacy teams in delivering care for patients with minor illnesses and supporting the public to live healthier lives;
  • Pharmacist prescribers will be a central part of multidisciplinary teams in Primary Care Networks (PCNs);
  • Appointing experienced pharmacists as clinical directors of pharmacy and medicines in every Integrated Care System; and
  • Strengthening the image and reputation of pharmacy teams to attract a larger and wider pool of people to the future pharmacy workforce.

You can read the full PSNC article HERE.


May 23, 2019 News0

The following communication originates from NHS Herefordshire CCG, but it’s also relevant for  Warwickshire and Coventry pharmacies.

Community pharmacy colleagues are reminded about the management of insect bites, particularly the notorious Blandford flies, which are on the increase in hot conditions at this time of year.

Please would you ensure that all pharmacy staffs are briefed on how best to self-manage these bites using the information as below which is also available on the NHS Choices website HERE.

N.B. Patients do not need to see their GP practice team unless the points under the medical advice section below are applicable.

As the weather warms up and we head towards the summer, the number of Blandford fly cases is increasing.

The Blandford fly is a 2 to 3mm bloodsucking black fly, which lives near areas of water and gives a particularly nasty and painful bite.  The fly normally bites ankles and legs, as it flies low to the ground and is most common during May and June.

Karen Wright, Director of Public Health for Herefordshire, said:

“As the weather starts to get warmer, it is likely that we will see more cases of Blandford fly bites across the county. 

“We encourage people to take precautions if they’re out and about on our rivers and streams, especially over the forthcoming bank holiday weekends, by covering up and using a good quality insect repellent.  If you do get bitten, it can often feel very uncomfortable with swelling, blistering, joint pain and sometimes a high temperature.  However, there’s normally no need to visit a GP. 

“If you do feel unwell after a bite, please call NHS 111 or visit your local pharmacy for advice on how to ease your discomfort.  For the majority of people, the symptoms will only last a few days before clearing up.”

If you get bitten:

  1. Clean the bite area and dry gently
  2. Don’t scratch the bite, as this can lead to infection
  3. Apply a cold compress or calamine lotion
  4. Antihistamine creams are not recommended, as they can sometimes cause skin reactions
  5. Cover large blisters with a dry dressing
  6. If bites are on the lower limbs, there may be swelling of the ankles and feet for several days.  Don’t worry about this, simply rest with your feet supported on a stool

You should seek medical advice if you have:

  1. Discomfort, swelling or red lines in the groin or armpit
  2. A fever
  3. A spreading redness or hotness around the bite, which lasts longer than three days

A link to this information is available HERE.



May 23, 2019 News0

The following news article was submitted to us by Vicki Roberts, one of our LPC members. We welcome submissions from all our contractors – if you have taken part in an event and have an article/photos to share, we’ll be happy to publish them. Please email articles and photos to Susan at

On Saturday 18th May Coventry and Warwickshire Partnership Trust in collaboration with the local councils held a Year of Wellbeing festival in Broadgate, Coventry.  As part of our engagement with local stakeholders LloydsPharmacy agreed to take part and showcase how community pharmacy can support health and wellbeing.

We decided to focus on general services and advice available in a typical community pharmacy and pulled together an eye catching summer health display which attracted people to come and have a chat.

There were 30 stalls and numerous activities going on throughout the day and LloydsPharmacy were the only commercial brand represented amongst the other health and wellbeing organisations.

Surprisingly, from the conversations we had, there is still a lack of awareness around what pharmacies have to offer.  People were interested to hear about healthy living pharmacy, medicines support and locally commissioned services and some even took up the opportunity to have their blood pressure checked by Daisy Darkwa, Professional Standards Pharmacist.

The festival gave us a fantastic opportunity to raise the awareness of community pharmacy and, following the success of the event, we have already been invited to take part in future activities in different parts of the local area.

Photos (use the arrows in the slider to view all photos)


May 21, 2019 News0

De Montfort University (DMU) is running a postgraduate quality improvement module in collaboration with Warwickshire LPC, extended to Coventry and Herefordshire/Worcestershire LPCs, to make postgraduate education more accessible to community pharmacists via the Pharmacy Integration Fund.

The first face-to-face session of the course took place on Sunday in the Citrus Hotel in Coventry with 15 students attending. Here are a few photos to document the event (use the arrows in the slider to view more photos or play the slideshow).  A big thank you to all participants, tutors and organisers who made this event possible. We hope that this post-graduate programme focusing on quality improvement will benefit, not only the individual participants but also the pharmacies and the wider community as a whole.

The next face-to-face session is scheduled for 23rd June with online tutoring between the two dates. Good luck to all of the students with their assignments!

These photos and some resource materials are also available on our DMU page HERE.


May 21, 2019 News0

Pharmacy contractors have been advised that there’s an imminent supply issue with Epanutin 50mg Infatabs. Pfizer, the sole supplier of Epanutin (phenytoin base 50mg) Infatabs have experienced global delays in the manufacturing of this product.  As a result, they are anticipating an imminent gap in supply until early November 2019 when their next batch arrives.

The MHRA has classified phenytoin as a Category 1 antiepileptic drug. In the event that you need to prescribe a product from a different manufacturer then this must be carefully managed and increased monitoring of the patient may be required as clinically relevant differences between different manufacturers’ products might occur. Pfizer have been able to secure supplies of a Canadian phenytoin base Infatabs (brand name Dilantin 50mg Infatabs), which will be available when current supplies of Epanutin Infatabs are depleted. Further information on this is attached and below:

  • Pfizer are confident they have sufficient supplies of Dilantin 50mg Infatabs to meet demand for Epanutin 50mg Infatabs to cover the full out of stock period. However, Dilantin will be considered an unlicensed medicine in the UK
  • The active ingredient in Epanutin 50 mg Infatabs and Dilantin 50 mg Infatabs is the same, however in the absence of bioequivalence data from Pfizer, there may be clinically relevant differences between the two products. Further information on this can be found in the DHCP letter and documents attached
  • Switching to alternative presentations should be managed under medical supervision and monitoring of phenytoin serum levels are advised to ensure the correct dosage is being given.
  • Epanutin 30 mg/5 ml Oral Suspension remains available, however, supplies are only available to meet normal market demandas such patients should not be switched to Epanutin Oral Suspension as this may precipitate a shortage of this presentation
  • General Practitioners should identify all patients currently prescribed Epanutin 50mg Infatabs. Early contact should be made with the patient or the patient’s parent/carer to determine if and when switches are likely to be required during this stock out period.
  • Alternative formulations of phenytoin continue to remain available including tablets, capsules and injections

Details on prescribing and ordering

  • If a clinician chooses to prescribe Dilantin 50mg Infatabs, they should be aware this is an unlicensed medicine in the UK.
  • Any decision to prescribe an unlicensed medicine must take into account the relevant GMC guidance and NHS Trust governance procedures. Please see link to GMC guidance:

  • Prescribers should ensure that they issue a prescription for the unlicensed product and clearly mark on the prescription that this is a special/unlicensed product. This is to ensure the pharmacy/contractor is reimbursed appropriately.
  • Pharmacies/ contractors may be unable to dispense Dilantin 50mg Infatabs and/or be reimbursed if the prescription states Epanutin.
  • Pharmacies/contractors wishing to order Dilantin should contact Pfizer Customer Contact Centre on 0845 608 8866 directly who will manage the order.

Please find some supporting documents below:

Dilantin Infatab DHCP letter -CCC (Final version)
Dilantin PIL
Epanutin Infatabs PIL

All this information will remain available on our website on the following page, until the supply issue is resolved:


Providing information for Community Pharmacies about the work of the Local Pharmaceutical Committee and of the Community Pharmacy Services commissioned within Coventry


Copyright by Coventry LPC. All rights reserved.